ABR-217620

DRUG2 trials

Sponsors

Active Biotech AB

Conditions

Carcinoma, Non-Small-Cell LungNon-Small-Cell Lung CarcinomaPancreatic CancerRenal Cell Carcinoma

Phase 1

ABR-217620 in Patients With Advanced Non-Small Cell Lung Cancer, Renal Clear Cell Carcinoma or Pancreatic Cancer

CompletedNCT00056537

Active Biotech ABNon-Small-Cell Lung Carcinoma, Pancreatic Cancer, Renal Cell Carcinoma

Start: 2003-04-30End: 2006-12-31Updated: 2014-08-27

ABR-217620 in Combination With Docetaxel in Patients With Advanced Non-small Cell Lung Cancer

CompletedNCT00132379

Active Biotech ABCarcinoma, Non-Small-Cell Lung

Start: 2005-11-30End: 2006-12-31Updated: 2014-08-27